Overview
Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy for decades 1. Suboptimal vaccination coverage in adults has limited further reduction in hepatitis B virus (HBV) infections 1.Diagnosis
No diagnostic criteria or recommended tests are mentioned in the provided abstracts.Management
Universal Hepatitis B vaccination is recommended for adults aged 19-59 years 1.
Removing the previous risk factor assessment for vaccine eligibility in this age group may increase vaccination coverage 1.Special Populations
No information on special populations is provided in the abstracts.Key Recommendations
Universal Hepatitis B vaccination should be recommended for adults aged 19-59 years 1. (Evidence: Expert opinion)
The assessment of risk factors to determine Hepatitis B vaccine eligibility in adults aged 19-59 years should be removed 1. (Evidence: Expert opinion)
Hepatitis B vaccines have demonstrated safety, immunogenicity, and efficacy over the past 4 decades 1. (Evidence: Moderate)References
1 Weng MK, Doshani M, Khan MA, Frey S, Ault K, Moore KL et al.. Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR. Morbidity and mortality weekly report 2022. link